Correlation Between Edgewise Therapeutics and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Edgewise Therapeutics and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Conduit Pharmaceuticals.
Diversification Opportunities for Edgewise Therapeutics and Conduit Pharmaceuticals
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Edgewise and Conduit is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Conduit Pharmaceuticals
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Conduit Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 8.35 times less risky than Conduit Pharmaceuticals. The stock trades about -0.14 of its potential returns per unit of risk. The Conduit Pharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1.05 in Conduit Pharmaceuticals on August 24, 2024 and sell it today you would lose (0.16) from holding Conduit Pharmaceuticals or give up 15.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 50.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| Edgewise Therapeutics |
| Conduit Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Weak
Edgewise Therapeutics and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Conduit Pharmaceuticals
The main advantage of trading using opposite Edgewise Therapeutics and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| Edgewise Therapeutics vs. ZyVersa Therapeutics | Edgewise Therapeutics vs. Sonnet Biotherapeutics Holdings | Edgewise Therapeutics vs. Zura Bio Limited | Edgewise Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |